Log in
NYSEAMERICAN:PTN

Palatin Technologies News Headlines

$0.54
+0.02 (+3.86 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.50
Now: $0.54
$0.54
50-Day Range N/A
52-Week Range
$0.36
Now: $0.54
$0.99
Volume877,705 shs
Average Volume1.86 million shs
Market Capitalization$123.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Palatin Technologies (NYSEAMERICAN PTN) News Headlines Today

Source:
DateHeadline
Palatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment ConferencePalatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment Conference
finance.yahoo.com - September 10 at 7:08 PM
Palatin Technologies (NYSEAMERICAN:PTN) Trading Up 6.2%Palatin Technologies (NYSEAMERICAN:PTN) Trading Up 6.2%
americanbankingnews.com - September 8 at 7:14 PM
Palatin Technologies (NYSEAMERICAN:PTN)  Shares Down 5.9% Palatin Technologies (NYSEAMERICAN:PTN) Shares Down 5.9%
americanbankingnews.com - September 1 at 7:49 PM
Palatin Technologies (NYSEAMERICAN:PTN) Share Price Crosses Above 200-Day Moving Average of $0.00Palatin Technologies (NYSEAMERICAN:PTN) Share Price Crosses Above 200-Day Moving Average of $0.00
americanbankingnews.com - September 1 at 2:05 AM
Palatin Technologies Participates In Canaccord Genuitys 40th Annual Growth ConferencePalatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference
prnewswire.com - August 13 at 5:56 PM
Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth ConferencePalatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference
finance.yahoo.com - August 13 at 5:56 PM
Palatin Technologies, Inc. Announces Completion of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye DiseasePalatin Technologies, Inc. Announces Completion of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease
prnewswire.com - August 5 at 7:37 AM
Palatin Tech and Amag Pharma ax Vyleesi agreementPalatin Tech and Amag Pharma ax Vyleesi agreement
seekingalpha.com - July 27 at 9:32 AM
Modernas COVID-19 Vaccine And Other News: The Good, Bad And Ugly Of BiopharmaModerna's COVID-19 Vaccine And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 12 at 7:07 AM
Palatin resumes enrollment in mid-stage dry eye studyPalatin resumes enrollment in mid-stage dry eye study
seekingalpha.com - July 8 at 10:10 AM
Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye DiseasePalatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease
finance.yahoo.com - July 8 at 8:51 AM
Palatin Technologies Announces Adjournment of Annual Meeting of StockholdersPalatin Technologies Announces Adjournment of Annual Meeting of Stockholders
finance.yahoo.com - June 29 at 8:00 AM
Palatins stock rises on plans to test experimental drug as COVID-19 treatmentPalatin's stock rises on plans to test experimental drug as COVID-19 treatment
www.msn.com - June 23 at 10:09 AM
Palatin Technologies Developing PL8177 As Treatment For COVID-19 - Quick FactsPalatin Technologies Developing PL8177 As Treatment For COVID-19 - Quick Facts
www.nasdaq.com - June 23 at 10:09 AM
Palatin's stock rises on plans to test experimental drug as COVID-19 treatmentPalatin's stock rises on plans to test experimental drug as COVID-19 treatment
finance.yahoo.com - June 23 at 10:09 AM
Do Hedge Funds Love Palatin Technologies, Inc. (PTN)?Do Hedge Funds Love Palatin Technologies, Inc. (PTN)?
finance.yahoo.com - June 5 at 6:11 PM
Palatin Technologies (PTN) Q3 2020 Earnings Call TranscriptPalatin Technologies (PTN) Q3 2020 Earnings Call Transcript
finance.yahoo.com - May 27 at 8:20 AM
Palatin Stock Could Soar by Over 300% in the Next Year, Says Top AnalystPalatin Stock Could Soar by Over 300% in the Next Year, Says Top Analyst
finance.yahoo.com - May 14 at 8:27 PM
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q3 2020 Results - Earnings Call TranscriptPalatin Technologies, Inc. (PTN) CEO Carl Spana on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 4:15 PM
EARNINGS SUMMARY: Details of Palatin Technologies Inc. Q3 Earnings ReportEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q3 Earnings Report
www.nasdaq.com - May 12 at 9:02 AM
Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business OperationsPalatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations
finance.yahoo.com - April 30 at 6:12 PM
Does Palatin Technologies, Inc.'s (NYSEMKT:PTN) CEO Salary Compare Well With Others?Does Palatin Technologies, Inc.'s (NYSEMKT:PTN) CEO Salary Compare Well With Others?
finance.yahoo.com - March 28 at 3:35 PM
Palatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other SelePalatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Sele
www.bloomberg.com - March 26 at 10:43 PM
Palatin Technologies (PTN) - Cash FlowPalatin Technologies (PTN) - Cash Flow
www.fool.com - March 25 at 10:56 PM
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 ResultsPalatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results
www.bloomberg.com - March 24 at 10:56 PM
Introducing Palatin Technologies (NYSEMKT:PTN), A Stock That Climbed 69% In The Last Three YearsIntroducing Palatin Technologies (NYSEMKT:PTN), A Stock That Climbed 69% In The Last Three Years
finance.yahoo.com - February 21 at 12:35 PM
Mid-stage study underway evaluating Palatins PL9643Mid-stage study underway evaluating Palatin's PL9643
seekingalpha.com - February 19 at 5:09 PM
Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643
finance.yahoo.com - February 19 at 7:38 AM
Palatin Technologies (PTN) Q2 2020 Earnings Call TranscriptPalatin Technologies (PTN) Q2 2020 Earnings Call Transcript
www.msn.com - February 11 at 11:57 PM
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q2 2020 - Earnings Call TranscriptPalatin Technologies, Inc. (PTN) CEO Carl Spana on Q2 2020 - Earnings Call Transcript
seekingalpha.com - February 11 at 5:29 PM
Palatin Technologies, Inc. Common Stock (PTN) Earnings Report DatePalatin Technologies, Inc. Common Stock (PTN) Earnings Report Date
www.nasdaq.com - February 11 at 12:29 PM
Palatin Tech EPS misses by $0.01, misses on revenuePalatin Tech EPS misses by $0.01, misses on revenue
seekingalpha.com - February 11 at 8:55 AM
Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business HighlightsPalatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights
www.prnewswire.com - February 11 at 7:42 AM
Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on February 11, 2020Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on February 11, 2020
finance.yahoo.com - February 6 at 8:04 AM
Palatin provides 2020 outlookPalatin provides 2020 outlook
seekingalpha.com - January 21 at 4:24 PM
Palatin Provides Corporate Update and 2020 Calendar OutlookPalatin Provides Corporate Update and 2020 Calendar Outlook
finance.yahoo.com - January 21 at 8:09 AM
Should We Be Delighted With Palatin Technologies, Inc.'s (NYSEMKT:PTN) ROE Of 38%?Should We Be Delighted With Palatin Technologies, Inc.'s (NYSEMKT:PTN) ROE Of 38%?
finance.yahoo.com - January 16 at 12:03 PM
Is Palatin Technologies, Inc. (PTN) Going To Burn These Hedge Funds ?Is Palatin Technologies, Inc. (PTN) Going To Burn These Hedge Funds ?
finance.yahoo.com - December 20 at 5:22 PM
Is Palatin Technologies, Inc. (NYSEMKT:PTN) A Volatile Stock?Is Palatin Technologies, Inc. (NYSEMKT:PTN) A Volatile Stock?
finance.yahoo.com - December 11 at 1:36 PM
Edited Transcript of PTN earnings conference call or presentation 13-Nov-19 4:00pm GMTEdited Transcript of PTN earnings conference call or presentation 13-Nov-19 4:00pm GMT
finance.yahoo.com - November 18 at 6:57 PM
Palatin Technologies (PTN) Q1 2020 Earnings Call TranscriptPalatin Technologies (PTN) Q1 2020 Earnings Call Transcript
www.fool.com - November 13 at 10:52 PM
BRIEF-Palatin Technologies Reports Q1 Loss Per Share Of $0.02BRIEF-Palatin Technologies Reports Q1 Loss Per Share Of $0.02
www.msn.com - November 13 at 7:46 PM
Palatin Technologies (PTN) CEO Carl Spana on Q1 2020 Results - Earnings Call TranscriptPalatin Technologies' (PTN) CEO Carl Spana on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 5:51 PM
EARNINGS SUMMARY: Details of Palatin Technologies Inc. Q1 Earnings ReportEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q1 Earnings Report
www.nasdaq.com - November 13 at 7:51 AM
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate UpdatePalatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate Update
finance.yahoo.com - November 13 at 7:51 AM
Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019
finance.yahoo.com - November 7 at 8:56 AM
Does Palatin Technologies (NYSEMKT:PTN) Deserve A Spot On Your Watchlist?Does Palatin Technologies (NYSEMKT:PTN) Deserve A Spot On Your Watchlist?
finance.yahoo.com - October 31 at 1:17 PM
Palatin Technologies: Vyleesi Growth Potential And Milestone Payments Should Lift Share PricesPalatin Technologies: Vyleesi Growth Potential And Milestone Payments Should Lift Share Prices
seekingalpha.com - October 28 at 9:20 AM
Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide TherapeuticsPalatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics
finance.yahoo.com - October 17 at 8:41 AM
Vyleesi™ Phase 3 Data To Be Presented At The 13th European Society Of Gynecology CongressVyleesi™ Phase 3 Data To Be Presented At The 13th European Society Of Gynecology Congress
finance.yahoo.com - October 16 at 7:44 AM
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.